| Ident. | Authors (with country if any) | Title |
|---|
| 000003 (2021) |
Joshuan J. Barboza [Pérou] ; Diego Chambergo-Michilot [Pérou] ; Mariana Velasquez-Sotomayor [Pérou] ; Christian Silva-Rengifo [Pérou] ; Carlos Diaz-Arocutipa [Pérou] ; Jose Caballero-Alvarado [Pérou] ; Franko O. Garcia-Solorzano [Pérou] ; Christoper A. Alarcon-Ruiz [Pérou] ; Leonardo Albitres-Flores [Pérou] ; German Malaga [Pérou] ; Patricia Schlagenhauf [Suisse] ; Alfonso J. Rodriguez-Morales [Colombie] | Assessment and management of asymptomatic COVID-19 infection: A systematic review. |
| 000014 (2021) |
Julio Echarte-Morales [Espagne] ; Carlos Minguito-Carazo [Espagne] ; Samuel Del Castillo-García [Espagne] ; Javier Borrego-Rodríguez [Espagne] ; Miguel Rodríguez-Santamarta [Espagne] ; Enrique Sánchez-Mu Oz [Espagne] ; Rubén Bergel-García [Espagne] ; Clea González-Maniega [Espagne] ; Silvia Prieto-González [Espagne] ; Paula Menéndez-Suarez [Espagne] ; Elena Tundidor-Sanz [Espagne] ; Tomás Benito-González [Espagne] ; Felipe Fernández-Vázquez [Espagne] | Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19. |
| 000020 (2021) |
Fabio Cruciani [Italie] ; Laura Amato [Italie] ; Franco De Crescenzo ; Zuzana Mitrova [Italie] ; Rosella Saulle [Italie] ; Simona Vecchi [Italie] ; Marina Davoli [Italie] | [The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.] |
| 000022 (2021) |
E. Díaz [Espagne] ; R. Amézaga Menéndez [Espagne] ; P. Vidal Cortés [Espagne] ; M G Escapa [Espagne] ; B. Suberviola [Espagne] ; A. Serrano Lázaro [Espagne] ; P. Marcos Neira [Espagne] ; M. Quintana Díaz [Espagne] ; M. Catalán González [Espagne] | [Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH)]. |
| 000035 (2021) |
L. Anedda [Italie] ; L. Bianchini ; L. Cuzzolin ; G. Finco ; V. Fanos ; M A Marcialis | What if COVID-19 affects the child: which weapons and how to use them. |
| 000043 (2021) |
Albert Prats-Uribe [Royaume-Uni] ; Anthony G. Sena [États-Unis, Pays-Bas] ; Lana Yin Hui Lai [Royaume-Uni] ; Waheed-Ul-Rahman Ahmed [Royaume-Uni] ; Heba Alghoul ; Osaid Alser [États-Unis] ; Thamir M. Alshammari [Arabie saoudite] ; Carlos Areia [Royaume-Uni] ; William Carter [États-Unis] ; Paula Casajust [Espagne] ; Dalia Dawoud [Égypte, Royaume-Uni] ; Asieh Golozar [États-Unis] ; Jitendra Jonnagaddala [Australie] ; Paras P. Mehta [États-Unis] ; Mengchun Gong [République populaire de Chine] ; Daniel R. Morales [Royaume-Uni, Danemark] ; Fredrik Nyberg [Suède] ; Jose D. Posada [États-Unis] ; Martina Recalde [Espagne] ; Elena Roel [Espagne] ; Karishma Shah [Royaume-Uni] ; Nigam H. Shah [États-Unis] ; Lisa M. Schilling [États-Unis] ; Vignesh Subbian [États-Unis] ; David Vizcaya [Espagne] ; Lin Zhang [République populaire de Chine, Australie] ; Ying Zhang [République populaire de Chine] ; Hong Zhu [République populaire de Chine] ; Li Liu [République populaire de Chine] ; Jaehyeong Cho [Corée du Sud] ; Kristine E. Lynch [États-Unis] ; Michael E. Matheny [États-Unis] ; Seng Chan You [Corée du Sud] ; Peter R. Rijnbeek [Pays-Bas] ; George Hripcsak [États-Unis] ; Jennifer Ce Lane [Royaume-Uni] ; Edward Burn [Royaume-Uni, Espagne] ; Christian Reich [États-Unis] ; Marc A. Suchard [États-Unis] ; Talita Duarte-Salles [Espagne] ; Kristin Kostka [États-Unis] ; Patrick B. Ryan [Slovénie, États-Unis] ; Daniel Prieto-Alhambra [Royaume-Uni] | Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study. |
| 000091 (2021) |
Fatemeh Sadat Hosseini [Iran] ; Alireza Malektojari [Iran] ; Sara Ghazizadeh [Iran] ; Mehdi Hassaniazad [Iran] ; Parivash Davoodian [Iran] ; Habib Dadvand [Iran] ; Amin Reza Nikpoor [Iran] ; Sara Nikoofal-Sahlabadi [Iran] ; Sara Kahoori [Iran] ; Mojtaba Sepandi [Iran] ; Soheil Hassanipour [Iran] ; Mohammad Fathalipour [Iran] | The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial. |
| 000114 (2021) |
Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Bhanuprasad Venkatesalu [États-Unis] ; Harsh K. Patel [États-Unis] ; Marco Spadaccini [Italie] ; Jacob Manteuffel [États-Unis] ; Mayur Ramesh [États-Unis] | Systematic review and meta-analysis of effectiveness of treatment options against SARS-CoV-2 infection. |
| 000136 (2021) |
T Y Andy Ko [Malaisie] ; L S Chen [Malaisie] ; I X Pang [Malaisie] ; H S Ling [Malaisie] ; T C Wong [Malaisie] ; L L Sia Tonnii [Malaisie] ; K T Koh [Malaisie] | Smartphone electrocardiogram for QT interval monitoring in Coronavirus Disease 2019 (COVID-19) patients treated with Hydroxychloroquine. |
| 000138 (2021) |
Katharina Habler [Allemagne] ; Mathias Brügel [Allemagne] ; Daniel Teupser [Allemagne] ; Uwe Liebchen [Allemagne] ; Christina Scharf [Allemagne] ; Ulf Schönermarck [Allemagne] ; Michael Vogeser [Allemagne] ; Michael Paal [Allemagne] | Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum. |
| 000160 (2021) |
Saeidreza Jamalimoghadamsiahkali [Iran] ; Besharat Zarezade [Iran] ; Sogol Koolaji [Iran] ; Seyedahmad Seyedalinaghi [Iran] ; Abolfazl Zendehdel [Iran] ; Mohammad Tabarestani [Iran] ; Ehsan Sekhavati Moghadam [Iran] ; Ladan Abbasian [Iran] ; Seyed Ali Dehghan Manshadi [Iran] ; Mohamadreza Salehi [Iran] ; Malihe Hasannezhad [Iran] ; Sara Ghaderkhani [Iran] ; Mohsen Meidani [Iran] ; Faeze Salahshour [Iran] ; Fatemeh Jafari [Iran] ; Navid Manafi [Canada] ; Fereshteh Ghiasvand [Iran] | Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial. |
| 000231 (2021) |
Venkata R. Emani [États-Unis] ; Sanjeev Goswami [États-Unis] ; Dheeraj Nandanoor [États-Unis] ; Shaila R. Emani [États-Unis] ; Nidhi K. Reddy [États-Unis] ; Raghunath Reddy [États-Unis] | Randomised controlled trials for COVID-19: evaluation of optimal randomisation methodologies-need for data validation of the completed trials and to improve ongoing and future randomised trial designs. |
| 000234 (2021) |
Carlos Diaz-Arocutipa [Pérou] ; Ana Bra Ez-Condorena [Pérou] ; Adrian V. Hernandez [Pérou, États-Unis] | QTc prolongation in COVID-19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta-analysis. |
| 000246 (2021) |
Jacobo Rogado [Espagne] ; Pedro Gull N [Espagne] ; Berta Obispo [Espagne] ; Gloria Serrano [Espagne] ; Miguel Lara [Espagne] | Prolonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors. |
| 000253 (2021) |
Leila Simani [Iran] ; Mahtab Ramezani [Iran] ; Ilad Alavi Darazam [Iran] ; Mastooreh Sagharichi [Iran] ; Mohammad Amin Aalipour [Iran] ; Fatemeh Ghorbani [Iran] ; Hossein Pakdaman [Iran] | Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. |
| 000294 (2021) |
Sanjay Kumar Mishra [Inde] ; Timir Tripathi [Inde] | One year update on the COVID-19 pandemic: Where are we now? |
| 000295 (2021) |
Zheng Zequn [République populaire de Chine] ; Wu Yujia [République populaire de Chine] ; Qian Dingding [République populaire de Chine] ; Lian Jiangfang [République populaire de Chine] | Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel. |
| 000297 (2021) |
Havva Kocayi It [Turquie] ; Kezban Özmen Süner [Turquie] ; Yakup Tomak [Turquie] ; Gürkan Demir [Turquie] ; Selçuk Yaylac [Turquie] ; Hamad Dheir [Turquie] ; Ertu Rul Güçlü [Turquie] ; Ali Fuat Erdem [Turquie] | Observational study of the effects of Favipiravir vs Lopinavir/Ritonavir on clinical outcomes in critically Ill patients with COVID-19. |
| 000307 (2021) |
Shweta A. More [Inde] ; Akshay S. Patil [États-Unis] ; Nikhil S. Sakle [Inde] ; Santosh N. Mokale [Inde] | Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs. |
| 000338 (2021) |
Florence Rodgers [Royaume-Uni] ; Toby Pepperrell [Royaume-Uni] ; Sarai Keestra [Pays-Bas, Royaume-Uni] ; Victoria Pilkington [Royaume-Uni] | Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs. |
| 000353 (2021) |
Ji-Won Kim [Corée du Sud] ; Eun Jin Kim [Corée du Sud] ; Hyun Hee Kwon [Corée du Sud] ; Chi Young Jung [Corée du Sud] ; Kyung Chan Kim [Corée du Sud] ; Jung-Yoon Choe [Corée du Sud] ; Hyo-Lim Hong [Corée du Sud] | Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019. |
| 000373 (2021) |
Irina Panovska-Stavridis ; Nevenka Ridova ; Tatjana Stojanoska ; Ilir Demiri ; Milena Stevanovic ; Simona Stojanovska ; Tara Ristevska ; Aleksandar Dimkovski ; Venko Filipce ; Aleksandar Dimovski ; Aleksandra Grozdanova | Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021). |
| 000412 (2021) |
Mario Karolyi [Autriche] ; Erich Pawelka [Autriche] ; Theresa Mader [Autriche] ; Sara Omid [Autriche] ; Hasan Kelani [Autriche] ; Sarah Ely [Autriche] ; Bernd Jilma [Autriche] ; Sebastian Baumgartner [Autriche] ; Hermann Laferl [Autriche] ; Clemens Ott [Autriche] ; Marianna Traugott [Autriche] ; Michael Turner [Autriche] ; Tamara Seitz [Autriche] ; Christoph Wenisch [Autriche] ; Alexander Zoufaly [Autriche] | Hydroxychloroquine versus lopinavir/ritonavir in severe COVID-19 patients : Results from a real-life patient cohort. |
| 000506 (2021) |
Barbara Burgos-Blasco [Espagne] ; Noemi Güemes-Villahoz [Espagne] ; Beatriz Vidal-Villegas [Espagne] ; Juan Donate-Lopez [Espagne] ; Julian Garcia-Feijoo [Espagne] | Evaluation of retinotoxicity of COVID-19 treatment: Hydroxychloroquine and lopinavir/ritonavir. |
| 000507 (2021) |
Meng Wang [République populaire de Chine] ; Ting Wu [République populaire de Chine] ; Zhihong Zuo [République populaire de Chine] ; Yaxian You [République populaire de Chine] ; Xinyuan Yang [République populaire de Chine] ; Liangyu Pan [République populaire de Chine] ; Ying Hu [République populaire de Chine] ; Xuan Luo [République populaire de Chine] ; Liping Jiang [République populaire de Chine] ; Zanxian Xia [République populaire de Chine] ; Meichun Deng [République populaire de Chine] | Evaluation of current medical approaches for COVID-19: a systematic review and meta-analysis. |
| 000508 (2021) |
Payam Tabarsi [Iran] ; Saghar Barati [Iran] ; Hamidreza Jamaati [Iran] ; Sara Haseli [Iran] ; Majid Marjani [Iran] ; Afshin Moniri [Iran] ; Zahra Abtahian [Iran] ; Alireza Dastan [États-Unis] ; Sahar Yousefian [Iran] ; Raha Eskandari [Iran] ; Ali Saffaei [Iran] ; Fatemeh Monjazebi [Iran] ; Abdolbaset Vahedi [Iran] ; Farzaneh Dastan [Iran] | Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial. |
| 000511 (2021) |
Rujipas Sirijatuphat [Thaïlande] ; Yupin Suputtamongkol [Thaïlande] ; Nasikarn Angkasekwinai [Thaïlande] ; Navin Horthongkham [Thaïlande] ; Methee Chayakulkeeree [Thaïlande] ; Pinyo Rattanaumpawan [Thaïlande] ; Pornpan Koomanachai [Thaïlande] ; Susan Assanasen [Thaïlande] ; Yong Rongrungruang [Thaïlande] ; Nitipatana Chierakul [Thaïlande] ; Ranistha Ratanarat [Thaïlande] ; Anupop Jitmuang [Thaïlande] ; Walaiporn Wangchinda [Thaïlande] ; Wannee Kantakamalakul [Thaïlande] | Epidemiology, clinical characteristics, and treatment outcomes of patients with COVID-19 at Thailand's university-based referral hospital. |
| 000520 (2021) |
Falasca Katia [Italie] ; Di Penta Myriam [Italie] ; Claudio Ucciferri [Italie] ; Antonio Auricchio [Italie] ; Marta Di Nicola [Italie] ; Michele Marchioni [Italie] ; Celletti Eleonora [Italie] ; Sabatini Emanuela [Italie] ; Francesco Cipollone [Italie] ; Jacopo Vecchiet [Italie] | Efficacy of canakinumab in mild or severe COVID-19 pneumonia. |
| 000527 (2021) |
Luigi Moschini [Italie] ; Marco Loffi [Italie] ; Valentina Regazzoni [Italie] ; Giuseppe Di Tano [Italie] ; Elisa Gherbesi [Italie] ; Gian Battista Danzi [Italie] | Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection. |
| 000531 (2021) |
Zerrin Orbak [Turquie] ; Fuat Laloglu [Turquie] ; Hulya Akat [Turquie] | Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease. |
| 000544 (2021) |
Gilmar Reis [Brésil] ; Eduardo Augusto Dos Santos Moreira Silva [Brésil] ; Daniela Carla Medeiros Silva [Brésil] ; Lehana Thabane [Canada] ; Gurmit Singh [Canada] ; Jay J H. Park [Canada] ; Jamie I. Forrest [Canada] ; Ofir Harari [Canada] ; Castilho Vitor Quirino Dos Santos [Brésil] ; Ana Paula Figueiredo Guimarães De Almeida [Brésil] ; Adhemar Dias De Figueiredo Neto [Brésil] ; Leonardo Cançado Monteiro Savassi [Brésil] ; Aline Cruz Milagres [Brésil] ; Mauro Martins Teixeira [Brésil] ; Maria Izabel Campos Simplicio [Brésil] ; Luciene Barra Ribeiro [Brésil] ; Rosemary Oliveira [Brésil] ; Edward J. Mills [Canada] | Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19: The TOGETHER Randomized Clinical Trial. |
| 000547 (2021) |
Steven M. Smoke [États-Unis] ; Karan Raja [États-Unis] ; Patrick Hilden [États-Unis] ; Nicole M. Daniel [États-Unis] | Early clinical outcomes with tocilizumab for severe COVID-19: a two-centre retrospective study. |
| 000548 (2021) |
Andrea Giacomelli [Italie] ; Gabriele Pagani [Italie] ; Anna L. Ridolfo [Italie] ; Letizia Oreni [Italie] ; Federico Conti [Italie] ; Laura Pezzati [Italie] ; Lucia Bradanini [Italie] ; Giacomo Casalini [Italie] ; Cinzia Bassoli [Italie] ; Valentina Morena [Italie] ; Simone Passerini [Italie] ; Giuliano Rizzardini [Italie, Afrique du Sud] ; Chiara Cogliati [Italie] ; Elisa Ceriani [Italie] ; Riccardo Colombo [Italie] ; Stefano Rusconi [Italie] ; Cristina Gervasoni [Italie] ; Dario Cattaneo [Italie] ; Spinello Antinori [Italie] ; Massimo Galli [Italie] | Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study. |
| 000593 (2021) |
Min Joo Choi [Corée du Sud] ; Minsun Kang [Corée du Sud] ; So Youn Shin [Corée du Sud] ; Ji Yun Noh [Corée du Sud] ; Hee Jin Cheong [Corée du Sud] ; Woo Joo Kim [Corée du Sud] ; Jaehun Jung [Corée du Sud] ; Joon Young Song [Corée du Sud] | Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study. |
| 000612 (2021) |
Jennifer Carron [Irlande (pays)] ; Zain Sharif [Irlande (pays)] ; Hafiz Hussein [Irlande (pays)] ; Mark Kennedy [Irlande (pays)] ; Brendan Mcadam [Irlande (pays)] ; Richard Sheahan [Irlande (pays)] | Clinical guidance for navigating the QTc-prolonging and arrhythmogenic potential of pharmacotherapy during the COVID-19 pandemic. |
| 000660 (2021) |
Jun Chen [République populaire de Chine] ; Danping Liu [République populaire de Chine] ; Lin Yin [République populaire de Chine] ; Lijun Zhang [République populaire de Chine] ; Hongzhou Lu [République populaire de Chine] | Can we use hydroxychloroquine to treat COVID-19 now? |
| 000679 (2021) |
Davide Colombi [Italie] ; Flavio Cesare Bodini [Italie] ; Nicola Morelli [Italie] ; Mario Silva [Italie] ; Gianluca Milanese [Italie] ; Luigi Cavanna [Italie] ; Emanuele Michieletti [Italie] | COVID-19 outbreak in Italy: Clinical-radiological presentation and outcome in three oncologic patients. |
| 000685 (2021) |
Berta Saez-Giménez [Espagne] ; Cristina Berastegui [Espagne] ; Miriam Barrecheguren [Espagne] ; Eva Revilla-L Pez [Espagne] ; Ibai Los Arcos [Espagne] ; Rodrigo Alonso [Espagne] ; Myriam Aguilar [Espagne] ; Víctor M. Mora [Espagne] ; Isabel Otero [Espagne] ; Juan P. Reig [Espagne] ; Carlos A. Quezada [Espagne] ; Virginia Pérez [Espagne] ; Manuel Valle [Espagne] ; Rosalía Laporta [Espagne] ; María Deu [Espagne] ; Judith Sacanell [Espagne] ; Carles Bravo [Espagne] ; Joan Gavalda [Espagne] ; Manuel Lopez-Meseguer [Espagne] ; Víctor Monforte [Espagne] | COVID-19 in lung transplant recipients: A multicenter study. |
| 000686 (2021) |
Carmen Guadalupe Rodriguez-Gonzalez [Espagne] ; Esther Chamorro-De-Vega [Espagne] ; Maricela Valerio [Espagne] ; Miguel Angel Amor-Garcia [Espagne] ; Francisco Tejerina [Espagne] ; Milagros Sancho-Gonzalez [Espagne] ; Alvaro Narrillos-Moraza [Espagne] ; Alvaro Gimenez-Manzorro [Espagne] ; Silvia Manrique-Rodriguez [Espagne] ; Marina Machado [Espagne] ; Maria Olmedo [Espagne] ; Vicente Escudero-Vilaplana [Espagne] ; Cristina Villanueva-Bueno [Espagne] ; Beatriz Torroba-Sanz [Espagne] ; Alejandra Melgarejo-Ortu O [Espagne] ; Juan Vicente-Valor [Espagne] ; Ana Herranz [Espagne] ; Emilio Bouza [Espagne] ; Patricia Mu Oz [Espagne] ; Maria Sanjurjo [Espagne] | COVID-19 in hospitalised patients in Spain: a cohort study in Madrid. |
| 000690 (2021) |
Carlotta Sciaccaluga [Oman] ; Matteo Cameli [Italie] ; Daniele Menci [Italie] ; Giulia Elena Mandoli [Italie] ; Nicol Sisti [Italie] ; Paolo Cameli [Italie] ; Federico Franchi [Italie] ; Sergio Mondillo [Italie] ; Serafina Valente [Italie] | COVID-19 and the burning issue of drug interaction: never forget the ECG. |
| 000694 (2021) |
Samuel A. Berkman [États-Unis] ; Victor F. Tapson [États-Unis] | COVID-19 and Its Implications for Thrombosis and Anticoagulation. |
| 000710 (2021) |
Jose Luis Rodriguez-Garcia ; Gines Sanchez-Nievas ; Juan Arevalo-Serrano ; Cristina Garcia-Gomez ; Jose Maria Jimenez-Vizuete ; Elisa Martinez-Alfaro [Espagne] | Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study. |
| 000713 (2021) |
O. Belfaqeeh [États-Unis] ; R N Janapala [États-Unis] ; J. Patel [États-Unis] ; A. Alhashmi [États-Unis] ; A. Pourmand [États-Unis] | Azithromycin, a questionable treatment for COVID-19. |
| 000729 (2021) |
Ambedkar Kumar Yadav [République populaire de Chine] ; Siwan Wen [République populaire de Chine] ; Xianghuai Xu [République populaire de Chine] ; Li Yu [République populaire de Chine] | Antiviral treatment in COVID-19: which is the most promising?-a narrative review. |
| 000730 (2021) |
Paolo Gaibani [Italie] ; Tommaso Tonetti [Italie] ; Michele Bartoletti [Italie] ; Maria Carla Re [Italie] ; Pierluigi Viale [Italie] ; V Marco Ranieri [Italie] | Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations. |
| 000754 (2021) |
Setareh Mamishi [Iran] ; Ameneh Navaeian [Iran] ; Reza Shabanian [Iran] | Acute aortic dissection in a patient with Williams syndrome infected by COVID-19. |
| 000762 (2021) |
Jiahong Tan [République populaire de Chine] ; Yuan Yuan [République populaire de Chine] ; Cheng Xu [République populaire de Chine] ; Chunyan Song [République populaire de Chine] ; Dan Liu [République populaire de Chine] ; Ding Ma [République populaire de Chine] ; Qinglei Gao [République populaire de Chine] | A retrospective comparison of drugs against COVID-19. |
| 000773 (2021) |
Dorna Kheirabadi [Iran] ; Fatemeh Haddad [Iran] ; Razieh S. Mousavi-Roknabadi [Iran] ; Mohammad Rezaeisadrabadi [Iran] ; Hamidreza Dehghan [Iran] ; Aylar Fazlzadeh [Iran] | A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic. |
| 000791 (2021) |
Soheila Aminimoghaddam [Iran] ; Narjes Afrooz [Iran] ; Setare Nasiri [Iran] ; Ozra Motaghi Nejad [Iran] ; Fatemeh Mahmoudzadeh [Iran] | A COVID-19 pregnant patient with thrombotic thrombocytopenic purpura: a case report. |
| 000805 (2020) |
Naeem A. Alshoaibi [Arabie saoudite] ; Khadijah Maghrabi [Arabie saoudite] ; Haitham Alanazi [Arabie saoudite] ; Mousa Al Harbi [Arabie saoudite] ; Saleh Alghamdi [Arabie saoudite] | Saudi Heart Rhythm Society Task Force on Management of Potential Arrhythmogenicity Associated with Pharmacotherapy for COVID-19. |
| 000807 (2020) |
Melanie Bilbul [États-Unis] ; Patricia Paparone [États-Unis] ; Anna M. Kim [États-Unis] ; Shruti Mutalik [États-Unis] ; Carrie L. Ernst [États-Unis] | Psychopharmacology of COVID-19. |
